Capillary electrochemical enzyme immunoassay (CEEI) for phenobarbital in serum

Journal of Pharmaceutical and Biomedical Analysis

Volumn 19, Issue 1-2, 1999, Pages 145-152

  Zhang, Jin ^a   Heineman, William R ^a   Halsall, H Brian ^a  

^a UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Capillary enzyme immunoassay; Electrochemical detection; Phenobarbital; Serum

Indexed keywords

PHENOBARBITAL;

AMPEROMETRY; ARTICLE; CONTROLLED STUDY; DRUG DETERMINATION; ELECTROCHEMICAL ANALYSIS; ENZYME IMMUNOASSAY; FLOW INJECTION ANALYSIS; METHODOLOGY; NONHUMAN; PRIORITY JOURNAL; SERUM;

ANTIBODIES; BINDING, COMPETITIVE; BUFFERS; CALIBRATION; ELECTROCHEMISTRY; ELECTROPHORESIS, CAPILLARY; HUMANS; HYDROLYSIS; HYPNOTICS AND SEDATIVES; IMMUNOENZYME TECHNIQUES; INDICATORS AND REAGENTS; OXIDATION-REDUCTION; PHENOBARBITAL; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 0032898447     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0731-7085(98)00053-3     Document Type: Article

References (42)

1. M.T. O'Connell, P.N. Patsalos, in: S. Shorvon (Ed.), The Treatment of Epilepsy, Blackwell, Oxford, 1996, pp. 446-453.
2. J. Aicardi, A. Arzimanoglou, in: S. Shorvon (Ed.), The Treatment of Epilepsy, Blackwell, Oxford, 1996, pp. 199-214.
3. J. Koch-Wesor, in: A. Richens, V. Marks (Eds.), Therapeutic Drug Monitoring, Churchill Livingston, London, 1981, pp. 1-22.
4. E. Perucca, A. Richens, in: A. Richens, V. Marks (Eds.), Therapeutic Drug Monitoring, Churchill Livingston London, 1981, pp. 320-348.
5. Gilman J.T., Gal P., Duchiwny M.S., Weaver R.L., Ransom J.L. Pediatrics. 83:1989;674-678.
6. G.H. Saunders, J.K. Penry, in: W.J. Taylor, A.L. Finn (Eds.), Individualizing Drug Therapy: Practical Applications of Drug Monitoring, vol. 2, Gross, Townsend, Frank, New York, 1981, pp. 49-62.
7. Chiinara I.A., Rane A. Clin. Pharmacokinet. 18(4):1990;318-328.
8. Lockman L.A., Kriel R., Zaske D., Thompson T., Virnig N. Neurology. 29:1979;1445.
9. Thomson H.A., Brodic M.J. Clin. Pharmacokinet. 23(3):1992;216-230.
10. E.H. Reynolds, Pharm. Ther. 8 217-235.
11. P. Routledge, in: D. Wild (Ed.), The Immunoassay Handbook, 1994, pp. 523-555.
12. Ratnaraj N., Goldberg V.D., Lascelles P.T. Analyst. 111:1986;517-523.
13. O'Connell M.T., Ratnaraj N., Elyas A.A., Daheny M.H., Darsot S., Patsalos P.N. Ther. Drug Monit. 17:1995;549-555.
14. V. Marks, in: A. Richens, V. Marks (Eds.), Therapeutic Drug Monitoring, Churchill Livingston, London, 1981, pp. 155-182.
15. Heineman W.R., Halsall H.B. Anal. Chem. 57:1985;1321A.
16. Wehmeyer K.R., Halsall H.B., Heineman W.R. Clin. Chem. 31:1985;1546.
17. Xu Y., Halsall H.B., Heineman W.R. J. Pharm. Biomed. Anal. 7:1989;1301.
18. Jenkins S.H., Halsall H.B., Heineman W.R. J. Clin. Immunol. 13:1990;99.
19. Halsall H.B., Heineman W.R., Jenkins S.H. Clin. Chem. 34:1988;1701.
20. Halsall H.B., Jenkins S.H., Heineman W.R., Doyle M.J., Wehmeyer K.R., Wright D.S. J. Res. Natl. Bur. Stand. 93:1988;491.
21. Halsall H.B., Heineman W.R. J. Int. Fed. Clin. Chem. 2:1990;179.
22. Wehmeyer K.R., Halsall H.B., Heineman W.R. Anal. Chem. 58:1986;135.
23. Gil E.P., Tang H., Halsall H.B., Heineman W.R., Misiego A.S. Clin. Chem. 36:1990;662.
24. Kaneki N., Xu Y., Kumari A., Halsall H.B., Heineman W.R., Kissinger P.T. Anal. Chim. Acta. 287:1994;253-258.
25. Jiang T., Halsall H.B., Heineman W.R., Giersch T., Hock B. J. Agric. Food Chem. 43:1995;1098.
26. Jenkins S.H., Halsall H.B., Heineman W.R. Adv. Biosens. 1:1991;171-228.
27. Nagainis P.A., Nakagawa C.H., Baron S.L., Fuller S.A., Chandler H.M., Hurrel J.G. Clin. Chim. Acta. 160:1986;273.
28. Chandler H.M., Fuller S.A., Nakagawa C.H., Nagainis P.A., Hurrel J.G. Clin. Chem. 33:1989;498.
29. Frutos M.D., Paliwal S.K., Regnier F.E. Anal. Chem. 65:1993;2159.
30. Thompson R.Q., Barone G.C., Halsall H.B., Heineman W.R. Anal. Biochem. 192:1991;90-95.
31. La Salle A.L.G., Limoges B., Degrand C. Anal. Chem. 67:1995;1245-1253.
32. Tang H.T., Lunte C.G., Halsall H.B., Heineman W.R. Anal. Chim. Acta. 214:1988;187-195.
33. Hoffman W., O'Shannessy D.J. J. Immunol. Methods. 112:1988;113-120.
34. Thompson R.Q., Porter M., Stuver C.et al. Anal. Chim. Acta. 271:1993;223-229.
35. C. Davies, in: D. Wild (Ed.), The Immunoassay Handbook, 1994, pp. 3-47.
36. S.S. Deshpande, Enzyme Immunoassay from Concept to Product Development, chap. 9, 1996.
37. Dijkhuis I.C. Pharm. Weekbl. Sci. Ed. 10:1988;138.
38. Wilson J.F., Tsanaclis L.M., Williams J., Tedstone J.E., Richens A. Ther. Drug Monit. 11:1989;185-195.
39. Tsanaclis L.M., Wilson J.F., Williams J., Perrett J.E., Richens A. Ther. Drug Monit. 12:1990;373-377.
40. Wilson J.F., Tsanaclis L.M., Perrett J.E., Williams J., Wicks J.F.C., Richens A. Ther. Drug Monit. 14:1992;98-106.
41. Prognon P., Pradier F., Chevallier A.et al. Biopharm. Drug Dispos. 8:1987;469-481.
42. J. Groff, in: D. Wild, (Ed.), The Immunoassay Handbook, 1994, pp. 143-148.